Volume 89 Issue 2 | p. 18 | Concentrates
Issue Date: January 10, 2011

Germany’s Merck Opens R&D Center In India

Department: Business
Keywords: Mumbai, India, biopharmaceutical
[+]Enlarge
Merck’s new R&D center in Mumbai.
Credit: Merck KGaA
8902buscon4_live-1
 
Merck’s new R&D center in Mumbai.
Credit: Merck KGaA

Merck KGaA has inaugurated an R&D center in Mumbai. Occupying 1,700 m2, the center will provide application development support for the entire Merck product range, “from drug discovery to automobile and decorative paints.” The center will incorporate technical capabilities stemming from its acquisition of Millipore last year, the firm adds. Separately, Merck has acquired Beijing Skywing Technology, a supplier of cell-culture media products and bioreactors for the Chinese biopharmaceutical industry. The purchase, for about $18 million, strengthens the former Millipore business in China, Merck says.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment